| 51 | 8819070 | Variant and masked translocations in acute promyelocytic leukemia. | Leuk Lymphoma | 1996 Jul |
4 |
| 52 | 8826895 | Successful treatment of acute promyelocytic leukaemia with all-trans-retinoic-acid during late pregnancy. | Br J Haematol | 1996 Sep |
4 |
| 53 | 8839862 | Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. | Blood | 1996 Oct 1 |
2 |
| 54 | 8874178 | The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. | Blood | 1996 Oct 15 |
3 |
| 55 | 8881287 | [Effect of PML and PML-RAR on the transactivation properties and subcellular localization of steroid hormone receptors]. | Ann Endocrinol (Paris) | 1996 |
3 |
| 56 | 8916959 | Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. | Blood | 1996 Nov 15 |
2 |
| 57 | 8952536 | Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. | Am J Pathol | 1996 Dec |
1 |
| 58 | 8956873 | Acute promyelocytic leukemia with t(15;16;17;19) and unusual fluorescence in situ hybridization pattern with PML and RARA probes. | Cancer Genet Cytogenet | 1996 Nov |
1 |
| 59 | 8986606 | The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. | Exp Cell Res | 1996 Dec 15 |
8 |
| 60 | 9016654 | Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. | Nucleic Acids Res | 1996 Dec 15 |
2 |
| 61 | 9089745 | Cutaneous infiltration by leukemic cells in acute promyelocytic leukemia of a child after treatment with all-trans retinoic acid. | Pediatr Hematol Oncol | 1997 Mar-Apr |
2 |
| 62 | 9103677 | Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. | Curr Top Microbiol Immunol | 1997 |
1 |
| 63 | 9108090 | Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. | Proc Natl Acad Sci U S A | 1997 Apr 15 |
9 |
| 64 | 9129042 | Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. | Blood | 1997 May 1 |
4 |
| 65 | 9192750 | A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. | Blood | 1997 Jun 15 |
4 |
| 66 | 9209367 | Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia. | Leukemia | 1997 Apr |
2 |
| 67 | 9234742 | Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling. | Mol Cell Biol | 1997 Aug |
9 |
| 68 | 9242550 | Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells. | Blood | 1997 Aug 1 |
5 |
| 69 | 9294197 | Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. | Proc Natl Acad Sci U S A | 1997 Sep 16 |
1 |
| 70 | 9369431 | Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia. | Leukemia | 1997 Nov |
7 |
| 71 | 9395203 | Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. | Carcinogenesis | 1997 Nov |
1 |
| 72 | 9398618 | Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. | Biochem Biophys Res Commun | 1997 Nov 26 |
2 |
| 73 | 9414089 | The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. | FEBS Lett | 1997 Nov 24 |
2 |
| 74 | 9417884 | Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. | Exp Cell Res | 1997 Nov 25 |
5 |
| 75 | 9427741 | Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. | EMBO J | 1998 Jan 2 |
2 |
| 76 | 9434633 | Transcriptional repression by the promyelocytic leukemia protein, PML. | Exp Cell Res | 1997 Dec 15 |
2 |
| 77 | 9450572 | Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. | J Natl Cancer Inst | 1998 Jan 21 |
1 |
| 78 | 9452416 | Covalent modification of PML by the sentrin family of ubiquitin-like proteins. | J Biol Chem | 1998 Feb 6 |
1 |
| 79 | 9460497 | Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia. | Cancer Genet Cytogenet | 1998 Feb |
2 |
| 80 | 9486654 | Role of the histone deacetylase complex in acute promyelocytic leukaemia. | Nature | 1998 Feb 19 |
2 |
| 81 | 9486655 | Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. | Nature | 1998 Feb 19 |
5 |
| 82 | 9531570 | Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. | Blood | 1998 Apr 15 |
5 |
| 83 | 9535176 | Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis. | Pharmacol Ther | 1997 Oct-Dec |
5 |
| 84 | 9558392 | Constitutive expression of the promyelocytic leukemia-associated oncogene PML-RARalpha in TF1 cells: isoform-specific and retinoic acid-dependent effects on growth, bcl-2 expression, and apoptosis. | Blood | 1998 May 1 |
5 |
| 85 | 9576546 | Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. | J Neurol Neurosurg Psychiatry | 1998 Apr |
3 |
| 86 | 9581846 | 4-Oxoretinol, a metabolite of retinol in the human promyelocytic leukemia cell line NB4, induces cell growth arrest and granulocytic differentiation. | Cancer Res | 1998 May 1 |
1 |
| 87 | 9591778 | The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies. | Oncogene | 1998 Apr 16 |
1 |
| 88 | 9596679 | Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. | Blood | 1998 Jun 1 |
6 |
| 89 | 9624536 | In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes. | Genes Chromosomes Cancer | 1998 Jul |
5 |
| 90 | 9657734 | Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. | Blood | 1998 Jul 15 |
2 |
| 91 | 9671405 | Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. | Oncogene | 1998 Jun 4 |
1 |
| 92 | 9671411 | Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. | Oncogene | 1998 Jun 4 |
3 |
| 93 | 9671498 | Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. | Mol Cell Biol | 1998 Aug |
1 |
| 94 | 9694705 | Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. | Blood | 1998 Aug 15 |
3 |
| 95 | 9716575 | Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. | Blood | 1998 Sep 1 |
17 |
| 96 | 9716606 | Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells. | Blood | 1998 Sep 1 |
2 |
| 97 | 9746761 | Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein. | Blood | 1998 Oct 1 |
10 |
| 98 | 9756909 | Identification of three major sentrinization sites in PML. | J Biol Chem | 1998 Oct 9 |
2 |
| 99 | 9772451 | [Double effects of arsenic trioxide (As2O3) on acute promyelocytic leukemic cell line]. | Zhonghua Yi Xue Za Zhi | 1997 Jul |
4 |
| 100 | 9778041 | Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells. | Oncogene | 1998 Oct 8 |
2 |